Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic …
…, U Bunworasate, T Puavilai… - The American journal …, 2012 - journals.lww.com
Extranodal NK/T-cell lymphoma (ENKTL), nasal type, may be of NK or T-cell origin; however,
the proportion of T-ENKTLs and whether they are of αβ or γδ type remains uncertain. To …
the proportion of T-ENKTLs and whether they are of αβ or γδ type remains uncertain. To …
Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta‐analysis
T Puavilai, K Thadanipon, S Rattanasiri… - British journal of …, 2020 - Wiley Online Library
Persistent immune thrombocytopenia (ITP) patients require second‐line treatments, for
which information on clinical outcomes are lacking. A systematic review and network meta‐…
which information on clinical outcomes are lacking. A systematic review and network meta‐…
Treatment outcome and prognostic factors in PCNSL
…, S Phusanti, K Boonyawat, T Puavilai… - Diagnostic …, 2019 - Springer
Objectives Standard treatment with a thiotepa-based regimen in countries with a limited
resource is less feasible. Aims of the study were to evaluate the treatment outcome, and identify …
resource is less feasible. Aims of the study were to evaluate the treatment outcome, and identify …
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
…, S Phusanti, K Boonyawat, T Puavilai… - … Hematology & Oncology, 2019 - Springer
Background Cytogenetic abnormalities and mutated genes indicate the role of consolidation
therapy with hematopoietic stem cell transplantation (HSCT) or chemotherapy in acute …
therapy with hematopoietic stem cell transplantation (HSCT) or chemotherapy in acute …
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen …
…, S Saengboon, P Niparuck, T Puavilai… - …, 2023 - Taylor & Francis
Introduction Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia
(AML) with a unique clinical presentation and prognosis. This study aimed to investigate …
(AML) with a unique clinical presentation and prognosis. This study aimed to investigate …
Prevalence of anti–platelet factor 4/polyanionic antibodies after COVID‐19 vaccination with ChAdOx1 nCoV‐19 and CoronaVac in Thais
…, P Niparuck, T Puavilai… - … and Practice in …, 2021 - Wiley Online Library
Introduction Vaccine‐induced thrombotic thrombocytopenia (VITT) has been reported after
vaccination with the adenoviral vector coronavirus disease 2019 (COVID‐19) vaccine …
vaccination with the adenoviral vector coronavirus disease 2019 (COVID‐19) vaccine …
The use of hematocrit level for predicting the efficiency of peripheral blood CD34+ cell collection after G‐CSF Mobilization in Healthy Donors
…, P Niparuck, R Kidkarn, T Puavilai… - Journal of Clinical …, 2015 - Wiley Online Library
Recently, peripheral blood stem cell (PBSC) has been widely used and replaced bone
marrow (BM) as the stem cell source in allogeneic hematopoietic stem cell transplantation (HSCT…
marrow (BM) as the stem cell source in allogeneic hematopoietic stem cell transplantation (HSCT…
External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free …
…, S Saengboon, P Chantrathammachart, T Puavilai… - …, 2022 - Taylor & Francis
Background Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive
lymphoma. The standard first-line therapy for DLBCL consists of rituximab cyclophosphamide …
lymphoma. The standard first-line therapy for DLBCL consists of rituximab cyclophosphamide …
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais
…, P Chantrathammachart, P Niparuck, T Puavilai… - Thrombosis …, 2023 - Springer
Background The prevalence of anti-platelet factor 4 (PF4)/polyanionic antibodies occurring
after vaccination with ChAdOx1 nCoV-19 is low. Most of these antibodies are not associated …
after vaccination with ChAdOx1 nCoV-19 is low. Most of these antibodies are not associated …
Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors
…, U Anurathapan, T Puavilai… - European Journal of …, 2024 - Wiley Online Library
Objectives Multiple myeloma (MM) accounts for 10% of hematologic malignancies. However,
most of the patients suffered from relapsed/refractory disease. We would like to expand …
most of the patients suffered from relapsed/refractory disease. We would like to expand …